Health and Happiness (H&H) International Holdings Limited

Core Business

Health and Happiness (H&H) International Holdings Limited has established itself as a uniquely positioned global consumer health and wellness enterprise, operating across three strategically complementary business segments including premium infant nutrition products, adult health and wellness supplements, and pet nutrition and health products, with a differentiated brand portfolio strategy that has enabled the company to achieve genuine multinational revenue diversification that is rare among Chinese-headquartered consumer health companies. In fiscal year 2025, the company achieved consolidated revenue of RMB 14.3 billion, representing an impressive year-on-year growth rate of 10.3 percent, while net profit attributable to shareholders increased by a robust 22.7 percent, demonstrating powerful operating leverage and successful brand investment returns across the company's diversified product portfolio. The Swisse brand, acquired by H&H Group and transformed into a genuinely global consumer wellness brand, achieved a landmark milestone during 2025 by surpassing one billion US dollars in global annual sales revenue, cementing its position as one of the world's leading premium vitamin, mineral, and supplement brands with particularly strong market positions in Australia, China, Southeast Asia, and progressively expanding presence in European and North American markets. The company's manufacturing and supply chain operations are anchored by a world-class production and logistics facility located in Melbourne, Australia, comprising over 17,000 square meters of advanced pharmaceutical-grade manufacturing and warehouse space, featuring three fully automated high-speed packaging production lines with a combined daily production capacity of 45,000 individual product units. This Melbourne facility serves as the company's global center of manufacturing excellence and primary export platform, producing Swisse and other H&H brand products for distribution to more than fifteen countries across the Asia-Pacific region, Europe, and the Americas. H&H Group employs approximately 2,800 personnel globally, distributed across the company's research and development centers, manufacturing facilities, regional sales offices, and brand marketing teams located in Australia, China, Hong Kong, France, the United Kingdom, Singapore, and the United States. In a significant demonstration of the company's commitment to sustainable business practices, H&H Group successfully achieved B Corporation certification during 2025, joining a select group of global consumer products companies that have met the rigorous social and environmental performance, accountability, and transparency standards required for this prestigious third-party certification. The company has also invested meaningfully in renewable energy infrastructure, with a 433 kilowatt solar panel installation at key operating facilities reducing the company's carbon footprint and energy costs.

Global Presence

H&H Group's international presence represents one of the most genuinely multinational operational footprints among Chinese-headquartered consumer health and wellness companies, with the company generating a very substantial and growing proportion of its total consolidated revenue from markets outside mainland China through its globally recognized brand portfolio and strategically distributed manufacturing and distribution infrastructure. The Swisse brand serves as the company's primary international growth engine, having achieved market leadership positions in Australia's vitamin and dietary supplement market, strong and growing market shares across Southeast Asian markets including Singapore, Malaysia, Thailand, Indonesia, and Vietnam, and progressively expanding distribution in European markets including Italy, the United Kingdom, the Netherlands, and selected markets in the Middle East. The company's Melbourne, Australia manufacturing and logistics center, occupying over 17,000 square meters and incorporating three fully automated high-speed packaging production lines with a combined daily output capacity of 45,000 product units, serves as the strategic manufacturing hub for the company's international operations, producing products that meet the stringent quality standards and regulatory requirements of multiple international markets simultaneously. H&H Group's international research and development capabilities are distributed across multiple geographic locations, enabling the company to access diverse scientific talent pools, collaborate with leading academic nutrition research institutions, and develop products tailored to the specific regulatory requirements and consumer preferences of different regional markets. The company has established dedicated sales subsidiaries and brand marketing teams in key international markets, reflecting a commitment to localized market development rather than relying exclusively on distributor partnerships or cross-border e-commerce channels. H&H Group's international product portfolio is exported to more than fifteen countries, with regulatory product registrations secured in each target market to ensure full compliance with local food, dietary supplement, and pharmaceutical regulations. The company's B Corporation certification, achieved in 2025, represents an internationally recognized credential that enhances brand credibility and consumer trust across diverse global markets, particularly in developed Western markets where sustainability and corporate social responsibility considerations increasingly influence consumer purchasing decisions.

Key Strengths

H&H Group's most powerful competitive advantage stems from its ownership and successful stewardship of the Swisse brand, which has been transformed from a primarily Australian-market vitamin brand into a genuinely global premium consumer wellness brand with annual sales exceeding one billion US dollars and a brand positioning that successfully bridges the gap between mass-market dietary supplements and premium lifestyle wellness products. The Swisse brand's celebrity endorsement strategy, premium packaging design, and aspirational brand marketing have created a consumer perception of premium quality and lifestyle relevance that commands price premiums relative to functionally similar competing products and generates exceptional brand loyalty and repeat purchase rates across diverse international markets. The company's multinational revenue diversification, with a very substantial and growing proportion of total revenue generated outside mainland China, provides important strategic risk mitigation against China-specific regulatory, economic, or competitive headwinds and represents a genuinely differentiated competitive characteristic relative to the overwhelming majority of Chinese consumer health companies. H&H Group's world-class Melbourne manufacturing and distribution facility, with its automated high-speed production lines capable of producing 45,000 units daily while maintaining pharmaceutical-grade quality standards, provides the manufacturing capacity, quality assurance infrastructure, and regulatory compliance capabilities required to serve sophisticated developed-country markets with stringent product quality requirements. The company's multi-brand, multi-category portfolio strategy, spanning infant nutrition, adult wellness supplements, and pet health products across multiple brand identities tailored to different consumer segments and price points, provides strategic flexibility, cross-category innovation opportunities, and resilience against category-specific demand fluctuations. The B Corporation certification achieved in 2025 provides tangible, third-party verified evidence of the company's commitment to social and environmental responsibility, a credential that is increasingly valued by consumers, retail channel partners, and institutional investors in developed international markets. The company's distributed research and development capabilities across multiple geographic locations provide access to diverse scientific expertise, facilitate product innovation tailored to local market requirements, and enable compliance with the varying regulatory frameworks governing dietary supplements and functional foods across different countries. H&H Group's commitment to renewable energy investment, evidenced by its 433 kilowatt solar installation, reflects an authentic operational commitment to environmental sustainability that aligns with evolving consumer expectations and regulatory requirements in developed international markets. VerityRank Score of 85/100

Health and Happiness H&H International Holdings Limited is a global consumer health and wellness enterprise operating across three complementary segments including premium infant nutrition, adult health supplements, and pet nutrition. The company achieved revenue of RMB 14.3 billion in 2025 with net profit surging 22.7%, powered by its flagship Swisse brand, which surpassed USD 1 billion in global annual sales and ranks among the world's leading premium vitamin and supplement brands. Manufacturing operations are anchored by a world-class 17,000 square meter facility in Melbourne, Australia, featuring three fully automated packaging lines with a combined daily capacity of 45,000 product units. The company employs approximately 2,800 personnel globally and exports products to more than 15 countries. In 2025, H&H Group achieved prestigious B Corporation certification and invested in 433 kW of solar energy infrastructure, demonstrating a strong commitment to environmental and social sustainability.

Adult nutrition supplements Swisse, vitamins, herbal extracts, infant formula, probiotic supplements, functional health beverages